<DOC>
	<DOCNO>NCT03037541</DOCNO>
	<brief_summary>Carac 0.5 % cream approve daily topical treatment AK 's four week tolerate , though local irritation often occur within first week treatment increase dose-dependent manner . In study , investigator examine combination standard cryosurgery treatment follow shortened course topical fluorouracil cram . The investigator anticipate one week treatment course maintain overall effectiveness combine previous cryosurgery , reduce overall adverse effect topical therapy due reduce treatment time presence few baseline lesion treat . This treatment approach may provide acceptable risk/benefit ratio option patient extensive disease simplify standard combination treatment option . The primary objective evaluate efficacy combination cryosurgery 5-fluorouracil0.5 % cream , compare combination cryosurgery placebo treatment actinic keratosis lesion . The efficacy combination therapy evaluate assess AK lesion clearance . The primary efficacy parameter 10 % clearance AK lesion treatment initiation end-of-treatment .</brief_summary>
	<brief_title>Cryosurgery Cream Combination Actinic Keratosis</brief_title>
	<detailed_description>This randomize ( 1:1 ) , single-blind , placebo control , single center prospective study . Subjects first undergo cryosurgery clinically apparent AK lesion , limited face bald scalp . Three week cryosurgery , subject randomize ( 1:1 accord standard randomization table ) direct apply either Carac 0.5 % cream placebo cream ( Cetaphil Cream ) face bald scalp bedtime seven consecutive day , wash follow morning . Each study cream apply approximately time day remain skin approximately eight hour . Subject evaluation , Investigator Global Assessments , Quality Life lesion count photography shall perform Baseline . At Week 3 , study drug dispense global assessment assessment improvement perform . A Medication Tolerability Assessment occur Week 4 study drug return . Investigator Global Assessment , lesion count , Global Assessment Improvement Quality Life measure Week 8 Week 26 ( end study ) . Photography do Week 26 end study .</detailed_description>
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis , Actinic</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Emollients</mesh_term>
	<criteria>Must male female least 18 year age . Each subject must demonstrate good health determine baseline medical history . Female subject myst either nonchildbearing potential , childbearing potential provide : negative urine pregnancy test use two acceptable method effective contraception ( abstinence , birth control pills.patch , DepoProvera , tubal ligation , vasectomy partner monogamous relationship , condom spermicidal form gel and/or cervical cap sponge ) , determine investigator At least eight clinically typical , visible discrete AK lesion within treatment area face bald scalp Subjects must able willing comply study procedure provide write informed consent . Cosmetic therapeutic procedure ( e.g. , use liquid nitrogen , surgical excision , curettage , dermabrasion , medium great depth chemical peel , laser resurfacing ) within select treatment area previous four week . Treatment systemic medication suppress immune system within previous four week . Field treatments topical 5FU , imiquimod , diclofenac , photodynamic therapy , widespread field treatment dermabrasion , medium great depth chemical peel , laser resurface within previous six month . Any known dihydropyrimidine dehydrogenase enzyme deficiency . In addition , subject skin condition disease may require concurrent therapy may confound evaluation determine investigator , history hypersensitivity formulation component exclude study . Subjects may use topical agent glycolic acid product , alphahydroxy acid product , retinoids chemical peel agent teh treatment area study . The use product allow four week prior study enrollment . Introduction prescription medication , topical systemic actinic keratosis participate study permit . Pregnant woman , woman breast feeding , woman childbearing potential practicing two acceptable method effective contraception .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Wake Forest</keyword>
	<keyword>Actinic Keratosis</keyword>
	<keyword>Cryosurgery</keyword>
	<keyword>Cream</keyword>
</DOC>